Professor Bach joins UCL and UCLH from the University of Birmingham and University Hospitals Birmingham, where he established an internationally recognised multidisciplinary clinical research programme focused on delivering kinder, safer and smarter treatments for patients with rectal cancer. His work has helped pioneer non‑operative outpatient treatment strategies that can spare selected patients major surgery and permanent stoma formation.
At UCL and UCLH, Prof Bach will work with colleagues to develop a research-aligned rectal cancer service that advances organ-preserving therapies and helps bring these innovations to patients worldwide.
Commenting on Simon’s appointment, Ramani Moonesinghe, Professor of Perioperative Medicine (UCL) and Honorary consultant in anaesthesia, perioperative and critical care medicine (UCLH) said: “I am delighted to welcome Professor Simon Bach to the Research Department for Targeted Intervention and our Division. A joint appointment with UCLH, Simon brings a wealth of clinical and academic expertise, particularly in organ‑preserving colorectal surgery and in the use of artificial intelligence to improve surgical performance, especially in robotic surgery”.
“These interests align closely with the 10‑year health plan for England, which sets out the government’s forward strategy for the NHS, including the development and implementation of advanced technologies to deliver better outcomes for patients, improve patient safety and reduce the need for hospitalisation.”
Professor Bach leads national research programmes focused on surgery, robotics and data‑driven approaches to improving surgical performance. This work aims to eliminate common technical errors responsible for avoidable patient harm and support the development of safer surgery.
I am delighted to join the Division of Surgery and Interventional Science at UCL and clinical colleagues at UCLH. I look forward to building new partnerships in clinical and translational research to transform patient care.
